History

OrganoBiotech is a biotech startup founded in 2021 out of Dr. Zhang’s lab at McMaster University, Canada. Its foundational research was supported by McMaster University, the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Canada Foundation for Innovation, among others. The company is based at the McMaster Innovation Park.

Vision

At OrganoBiotech, we develop advanced platform technologies that replicate complex biological processes to accelerate drug discovery. By combining state-of-the-art tissue models with generative AI, we enable deeper insights into human biology and strengthen confidence in new medicines. Our vision is to transform drug discovery through next-generation phenotypic modeling and data-driven innovation.

Meet the team

Boyang Zhang, Ph.D., P.Eng.

CEO & founder

Dawn Lin, Ph.D.

Scientific co-founder

Shravanthi Rajasekar, Ph.D.

Scientific co-founder

Samuel White, M.D.

Senior VP, CRCM Venture
Advisor

Alexander Sotra

Project Manager

Kimia Asadi Jozani

Project Manager

Sara Deir

Manufacturing Manager

Manvir Bhangu

Product Development and Commercialization Manager

OrganoBiotech
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.